Benzinga's Top Initiations

Analysts at Goldman Sachs initiated coverage on shares of Questcor Pharmaceuticals (NASDAQ: QCOR ) with a “neutral” rating. The target price for Questcor Pharmaceuticals is set to $71. Questcor's shares closed at $65.27 yesterday. Piper Jaffray initiated coverage on shares of PerkinElmer (NYSE: PKI ) with an “overweight”